Fluvoxamine gains approval for obsessive-compulsive disorder.
D017277:Drug Approval; D016666:Fluvoxamine / Q000627:therapeutic use*; D006801:Humans; D009771:Obsessive-Compulsive Disorder / Q000188:drug therapy*; D014481:United States
D016666:Fluvoxamine